Fuzhou University announced to the society a few days ago that the research group led by Professor Jin Lingling and Chen Naisheng of the school has successfully developed a new anticancer photosensitizer "Photocyanine".
Fuzhou University introduced that “Fudansaiin†is a new drug that can be used for photodynamic therapy of cancer diseases, and it is also the first chemically synthesized anticancer photosensitizer in China. The drug has been granted two national invention patents and has Independent intellectual property rights.
According to Professor Jin Ling’s introduction, photodynamic therapy is a new method for the treatment of cancer. Its role is through the dual synergies of drugs (photosensitizers) and lasers to selectively destroy lesions, with minimal damage to normal tissues and low toxicity. , Widely adapt to different types of cancer, can eliminate hidden cancer lesions, can protect the appearance and vital organs and other advantages.
According to Jin Ling, photosensitizers are the key and core drugs for photodynamic therapy. "Fu Dasai" belongs to the new generation of anticancer photosensitizers - phthalocyanine compounds, which have a strong ability to kill tumor cells in the light. . Compared with other photosensitizers, Fortune Sine has the advantages of stable properties, low doses, and low dark toxicity.
According to Fuzhou University, in March 2006, the Fujian Science and Technology Department organized an expert to appraise the results of the “Research and Industrialization of Novel Anticancer Photosensitizersâ€. The appraisal committee agreed that the research results “have reached the international advanced levelâ€. In June 2008, it was approved by the State Food and Drug Administration for clinical trials.
Fuzhou University announced that Phase I clinical trials of Fortune Scavenge recruit 18 to 24 patients aged 18 to 70 years across the country as subjects, receive free trials and be protected by ethics committees, and phase I trials The main diseases are esophageal and skin cancers.
Fuzhou University introduced that “Fudansaiin†is a new drug that can be used for photodynamic therapy of cancer diseases, and it is also the first chemically synthesized anticancer photosensitizer in China. The drug has been granted two national invention patents and has Independent intellectual property rights.
According to Professor Jin Ling’s introduction, photodynamic therapy is a new method for the treatment of cancer. Its role is through the dual synergies of drugs (photosensitizers) and lasers to selectively destroy lesions, with minimal damage to normal tissues and low toxicity. , Widely adapt to different types of cancer, can eliminate hidden cancer lesions, can protect the appearance and vital organs and other advantages.
According to Jin Ling, photosensitizers are the key and core drugs for photodynamic therapy. "Fu Dasai" belongs to the new generation of anticancer photosensitizers - phthalocyanine compounds, which have a strong ability to kill tumor cells in the light. . Compared with other photosensitizers, Fortune Sine has the advantages of stable properties, low doses, and low dark toxicity.
According to Fuzhou University, in March 2006, the Fujian Science and Technology Department organized an expert to appraise the results of the “Research and Industrialization of Novel Anticancer Photosensitizersâ€. The appraisal committee agreed that the research results “have reached the international advanced levelâ€. In June 2008, it was approved by the State Food and Drug Administration for clinical trials.
Fuzhou University announced that Phase I clinical trials of Fortune Scavenge recruit 18 to 24 patients aged 18 to 70 years across the country as subjects, receive free trials and be protected by ethics committees, and phase I trials The main diseases are esophageal and skin cancers.